133 related articles for article (PubMed ID: 28085512)
1. TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development.
Miranda P; Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2018 Jul; 55(6):865-870. PubMed ID: 28085512
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide Chromatin Mapping Defines AP2α in the Etiology of Craniofacial Disorders.
Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2015 Mar; 52(2):135-42. PubMed ID: 24641171
[TBL] [Abstract][Full Text] [Related]
3. ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2013 May; 50(3):347-50. PubMed ID: 23145914
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of Williams-Beuren syndrome: TFII-I regulated targets involved in craniofacial development.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2011 Jan; 48(1):109-16. PubMed ID: 20500075
[TBL] [Abstract][Full Text] [Related]
5. Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.
Makeyev AV; Enkhmandakh B; Hong SH; Joshi P; Shin DG; Bayarsaihan D
PLoS One; 2012; 7(9):e44443. PubMed ID: 22970219
[TBL] [Abstract][Full Text] [Related]
6. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
7. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
8. Modeling the Pathological Long-Range Regulatory Effects of Human Structural Variation with Patient-Specific hiPSCs.
Laugsch M; Bartusel M; Rehimi R; Alirzayeva H; Karaolidou A; Crispatzu G; Zentis P; Nikolic M; Bleckwehl T; Kolovos P; van Ijcken WFJ; Šarić T; Koehler K; Frommolt P; Lachlan K; Baptista J; Rada-Iglesias A
Cell Stem Cell; 2019 May; 24(5):736-752.e12. PubMed ID: 30982769
[TBL] [Abstract][Full Text] [Related]
9. Neural crest survival and differentiation in zebrafish depends on mont blanc/tfap2a gene function.
Barrallo-Gimeno A; Holzschuh J; Driever W; Knapik EW
Development; 2004 Apr; 131(7):1463-77. PubMed ID: 14985255
[TBL] [Abstract][Full Text] [Related]
10. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
11. Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain.
Li H; Sheridan R; Williams T
Hum Mol Genet; 2013 Aug; 22(16):3195-206. PubMed ID: 23578821
[TBL] [Abstract][Full Text] [Related]
12. Craniofacial phenotype in the branchio-oculo-facial syndrome: four case reports.
Galliani E; Burglen L; Kadlub N; Just W; Sznajer Y; de Villemeur TB; Soupre V; Picard A; Vazquez MP
Cleft Palate Craniofac J; 2012 May; 49(3):357-64. PubMed ID: 21539471
[TBL] [Abstract][Full Text] [Related]
13. TFAP2A mutations result in branchio-oculo-facial syndrome.
Milunsky JM; Maher TA; Zhao G; Roberts AE; Stalker HJ; Zori RT; Burch MN; Clemens M; Mulliken JB; Smith R; Lin AE
Am J Hum Genet; 2008 May; 82(5):1171-7. PubMed ID: 18423521
[TBL] [Abstract][Full Text] [Related]
14. TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.
Ohazama A; Sharpe PT
Dev Dyn; 2007 Oct; 236(10):2884-8. PubMed ID: 17823943
[TBL] [Abstract][Full Text] [Related]
15. A family with branchio-oculo-facial syndrome with primarily ocular involvement associated with mutation of the TFAP2A gene.
Dumitrescu AV; Milunsky JM; Longmuir SQ; Drack AV
Ophthalmic Genet; 2012 Jun; 33(2):100-6. PubMed ID: 22191992
[TBL] [Abstract][Full Text] [Related]
16. Identification of the TFII-I family target genes in the vertebrate genome.
Chimge NO; Makeyev AV; Ruddle FH; Bayarsaihan D
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9006-10. PubMed ID: 18579769
[TBL] [Abstract][Full Text] [Related]
17. Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA binding and long-term behavioral consequences.
Kopp ND; Nygaard KR; Liu Y; McCullough KB; Maloney SE; Gabel HW; Dougherty JD
Hum Mol Genet; 2020 Jun; 29(9):1498-1519. PubMed ID: 32313931
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation by TFII-I during embryonic stem cell differentiation.
Bayarsaihan D; Makeyev AV; Enkhmandakh B
J Cell Biochem; 2012 Oct; 113(10):3056-60. PubMed ID: 22628223
[TBL] [Abstract][Full Text] [Related]
19. 6p.24 microdeletion involving TFAP2A without classic features of branchio-oculo-facial syndrome.
LeBlanc SK; Yu S; Barnett CP
Am J Med Genet A; 2013 Apr; 161A(4):901-4. PubMed ID: 23495225
[No Abstract] [Full Text] [Related]
20. Additional clinical and molecular analyses of TFAP2A in patients with the Branchio-Oculo-Facial syndrome: Previously reported patient.
Reiber J; Sznajer Y; Posteguillo EG; Müller D; Lyonnet S; Baumann C; Just W
Am J Med Genet A; 2010 Aug; 152A(8):2143. PubMed ID: 20635357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
